Company: CI
Filing Date: 2025-03-14
Form Type: DEF 14A
Source: 0001739940-25-000015
Chunk: 9

Company: Cigna Group
Filing Date: 2025-03-14
Form: DEF 14A
Chunk 9
---
 achievement of a predetermined absolute financial goal and relative Total Shareholder Return (TSR) over a three-year performance period, with vesting at the end of the performance period. |     | 45%                                    |
| Long-Term Incentives (LTI)      |     | Stock Options                      |     | Performance-based equity incentive aligned with stock price appreciation, with ratable vesting over three years.                                                                                                                                  |     | 15%                                    |
|                                 |     | Restricted Stock                   |     | Performance-based equity incentive designed to promote strong retention and alignment with shareholders’ interests, with ratable vesting over three years.                                                                                        |     | 15%                                    |

<div align='center'>*Totals may not add to 100% due to rounding.

CEO LTI target at midpoint of target range</div>

| The Cigna Group| 2025 Notice of Annual Meeting of Shareholders and Proxy Statement |     | 7 |

| PROXY STATEMENT SUMMARY |

| Executive Compensation                                                                                                                                                                                                                                                                                                                                                                                                                    
 CEO compensation demonstrates our pay-for-performance philosophy and is aligned with the interests of our shareholders.                                                                                                                                                                                                                                                                                                                   
 The performance-based orientation of Mr. Cordani’s compensation reflects the Board’s view that executive compensation should incentivize superior performance in service of our mission, reward executives for the performance achieved, and be strongly aligned with the interests of our long-term shareholders. Grouping Mr. Cordani’s 2024 compensation into three distinct categories demonstrates the execution of this philosophy: |     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| 1                                                                                                                                                                                                                                                                                                                                                                                                                                         |     | Significant and growing investment in The Cigna Group.Between year-end 2020 and 2024, Mr. Cordani’s holdings of The Cigna Group common stock, net of unvested restricted stock, increased 38%, which, as of December 31, 2024, represents 0.22% of the Company’s outstanding shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 The increase in holdings includes shares acquired by Mr. Cordani in the first quarter of 2024, pursuant to the exercise of options granted to him in 2016 (see page89). The options were exercised pursuant to a Rule 10b5-1 trading plan that he entered into in May 2023. The $29.5M realized upon the exercise of options represents the largest component of his realized compensation in 2024. The exercised options, which had a ten-year term, had